COMMUNIQUÉS West-GlobeNewswire

GenVivo Highlights GEN-1013: A Novel Delivery of an IL-12 Immunotherapy at the 2025 American Association for Cancer Research (AACR) Annual Meeting
26/04/2025
GEN-1013 was studied in an aggressive CT26 murine cancer model using both IT and IV administration. Significant tumor reduction was observed in both administration routes. Both IT and IV were well-tolerated and [...]
Burnjaro Under Review: Analyzing the Results of Burn Jaro Slimming Ingredients to Instantly Burn Belly Fat
26/04/2025
Norcross, Georgia, April 26, 2025 (GLOBE NEWSWIRE) -- In This Article, You’ll Discover: Why belly fat is harder to lose in 2025—and the hidden factors behind the growing epidemic. The real-life obstacles that prevent [...]
Best Male Enhancement Pills For Men: Top OTC Sex Pills To Perform Better And Erectile Dysfunction, Over The Counter ED Pills (Performer 8)
26/04/2025
GLASGOW, United Kingdom, April 26, 2025 (GLOBE NEWSWIRE) -- Performer 8: A Natural Male Health Supplement How Does Performer 8 Work? As men age, especially after 40, they may face health issues like low energy, reduced [...]
Best Legal Steroids For Muscle Growth: Best Oral Steroids, Safest Steroids, Best Steroids for Muscle Gain, Best Steroid Cycle, Steroids best for muscle growth Anabolic Steroids vs Testosterone By CrazyBulk
26/04/2025
NEW YORK, April 26, 2025 (GLOBE NEWSWIRE) -- Benefits of Legal Steroids for Building Muscle Legal steroids are a safe and effective way to gain muscle and strength without the dangerous side effects of anabolic steroids [...]
Levicept Presents Positive Phase II Data for Novel Neurotrophin-3 Inhibitor, LEVI-04, at 2025 World Congress on Osteoarthritis
26/04/2025
Plenary presentation of data showing primary efficacy endpoint met – significant analgesia across all doses Significant improvement in all signs and symptoms of osteoarthritis for all doses Poster presentation of [...]
Financière de Tubize - Dividend approval
26/04/2025
Dividend confirmation Regulated information - 25 april 2025 The general shareholders meeting of 25 April 2025 has approved the annual accounts as at 31 December 2024, including the distribution of a gross dividend of € [...]
Financière de Tubize - Approbation du dividende
26/04/2025
Approbation du dividende Information réglementée - 25 avril 2025 L’assemblée générale des actionnaires du 25 avril 2025 a approuvé les comptes annuels relatifs à l’exercice social clôturé le 31 décembre 2024, en ce [...]
Hgh X2 Reviews 2025: Dosage ,Side Effects, Cycle (Human Growth Hormone For Muscle Growth) - HGH for Bodybuilding By Crazy Bulk
26/04/2025
New York City, April 26, 2025 (GLOBE NEWSWIRE) -- In bodybuilding, optimal muscle gain, strength, and bodybuilding are surpassed with intense training and strict dieting. For such a bodybuilder looking for a legal, [...]
Mitolyn Reviews 2025 (WARNING) Purple Peel Exploit Scientific Evidence, Complaints & What the Users Says About Mitochondrial Support!
26/04/2025
New York City, April 26, 2025 (GLOBE NEWSWIRE) -- More individuals wish to lose weight, feel more energetic, and become healthier. While most weight loss supplements offer immediate results, they can damage your long- [...]
Gluco6 Reviews (SHOCKING RESULTS) Is This Herbal Formula Control Blood Sugar Effectively or Over Hype?
26/04/2025
LOS ANGELES, April 26, 2025 (GLOBE NEWSWIRE) -- Gluco6 is a natural blood sugar support supplement emerging as a popular choice in the ever-growing market of anti-diabetic supplements. The formula targets some key [...]
VitaSeal Reviews (EXPERT OPINION) Does VitaSeal Really Work For Diabetes or Is It Just Hype? (Pros & Cons)
26/04/2025
MINNEAPOLIS, April 26, 2025 (GLOBE NEWSWIRE) -- VitaSeal is a natural blood sugar control formula that has been receiving much hype lately. The manufacturer claims this supplement is a combination of natural ingredients [...]
Skye Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
26/04/2025
SAN DIEGO, April 25, 2025 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”), a clinical-stage biopharmaceutical company focused on unlocking new therapeutic pathways for metabolic health, today announced [...]
Celularity Receives Nasdaq Notice Regarding Non-Payment of Nasdaq Fees
25/04/2025
FLORHAM PARK, N.J., April 25, 2025 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (“Celularity” or the “Company”), a cellular and regenerative medicine company, today announced that Nasdaq has notified the Company [...]
Rezolute, Inc. Announces Closing of Underwritten Offering
25/04/2025
NEW YORK, April 25, 2025 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT) (“Rezolute” or the “Company”), a late-stage biopharmaceutical company committed to developing novel, transformative therapies for serious rare [...]
New Data at AACR Annual Meeting Highlights Use of DecisionDx®-Melanoma to Identify Early-Stage Melanoma Patients at High Risk of Distant Metastasis
25/04/2025
FRIENDSWOOD, Texas, April 25, 2025 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, will share new research intended to improve [...]
Myriad Genetics Highlights MRD Clinical Validity Data at American Association for Cancer Research Annual Meeting
25/04/2025
Podium presentation showcases the clinical application of Precise™ MRD SALT LAKE CITY, April 25, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc . (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision [...]
Prelude Announces Presentations at 2025 AACR Annual Meeting
25/04/2025
Preclinical data elucidating the mechanism of action of PRT3789, Prelude’s first-in-class, highly selective SMARCA2 degrader currently in early clinical development Highlights from Prelude’s efforts to discover and [...]
AEON Biopharma Announces NYSE American Acceptance of Plan to Regain Listing Compliance
25/04/2025
IRVINE, Calif., April 25, 2025 (GLOBE NEWSWIRE) -- AEON Biopharma, Inc. (“AEON” or the “Company”) (NYSE: AEON), a clinical-stage biopharmaceutical company focused on developing a botulinum toxin complex for the [...]
SRx Health Solutions, Inc. (formerly known as Better Choice Company Inc.) Announces Halo Spin-Out Distribution for Stockholders of Record as of April 23, 2025
25/04/2025
TAMPA, Fla., April 25, 2025 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (formerly known as Better Choice Company Inc.) (NYSE American: BTTR) (the “Company”), a leading global health and wellness company, today [...]

Pages